Abstract
Epidemiologic studies suggest a strong genetic component for susceptibility to systemic lupus erythematosus (SLE). To investigate the genetic mechanism of pathogenesis of SLE, we studied the difference in gene expression of peripheral blood cells between 10 SLE patients and 18 healthy controls using oligonucleotide microarray. When gene expression for patients was compared to the mean of normal controls, among the 3002 target genes, 61 genes were identified with greater than a two-fold change difference in expression level. Of these genes, 24 were upregulated and 37 downregulated in at least half of the patients. By the Welch's ANOVA/Welch's t-test, all these 61 genes were significantly different (P<0.05) between SLE patients and normal controls. Among these genes with differential expression, IFN-ω and Ly6E (TSA-1/Sca-2) may play an important role in the mechanism of SLE pathogenesis. TSA-1 antigens may represent an important alternative pathway for T-cell activation that may be involved in IFN-mediated immunomodulation. Hierarchical clustering showed that patient samples were clearly separated from controls based on their gene expression profile. These results demonstrate that high-density oligonucleotide microarray has the potential to explore the mechanism of pathogenesis of systemic lupus erythematosus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Accessions
GenBank/EMBL/DDBJ
References
Hochberg MC . The epidemiology of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds). Dubois’ Lupus Erythematosus. Williams and Wilkins: Baltimore, 1997, pp 49–65.
Wakeland EK, Liu K, Graham RR, Behrens TW . Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001; 15: 397–408.
Deapen DM, Escalante A, Weinrib L, Horwitz DA, Mack M . A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311–318.
Vyse TJ, Todd JA . Genetic analysis of autoimmune diseases. Cell 1996; 85: 311–318.
Arnett FC . The genetic basis of lupus erythematosus. In: Wallace DJ, Hahn BH (eds). Dubois’ Lupus Erythematosus. Williams and Wilkins: Baltimore, 1997, pp 77–117.
Wu J, Edberg JC, Redecha PB et al. A novel polymorphism of Fcγ RIIIa(CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 1059–1070.
Tsao BP, Cantor RM, Kalunian KC et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997; 99: 725–731.
Shai R, Quismorio FP, Li L et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 1999; 8: 639–644.
Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 1998; 95: 14875–14879.
Gaffney PM, Ortmann WA, Selby SA et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of sib-pair families. Am J Hum Genet 2000; 66: 547–556.
Brown PO, Hartwell L . Genomics and human disease-variations on variation. Nature Genet 1998; 18: 91–93.
Derisi JL, Lyer VR, Brown PO . Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 1997; 278: 680–686.
Schena M, Shalon D, Davis RW et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467–470.
Heller RA, Schena M, Chai A et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 1997; 94: 2150–2155.
Lawrance IC, Fiocchi C, Chakravarti S . Ulcerative colitis and Crohn's diseases: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001; 10: 445–456.
Staudt LM . Gene expression physiology and pathophysiology of the immune system. Trends Immunol 2001; 22: 35–40.
Rus V, Atamas SP, Shustova V et al. Expression of cytokin- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol 2002; 102: 283–290.
Taniguchi M, Miura K, Iwao H, and Yamanaka S . Quantitative assessment of DNA microarray—comparison with Northern blot analyses. Genomics 2001; 71: 34–39.
Von Wussow P, Jakschies D, Hartung K, Deicher H . Presence of interferon and anti-interferon in patients with systemic lupus erythematosus. Rheumatol Int 1988; 8: 225–230.
Preble OT, Rothko K, Klippel JH, Friedman RM, Johnston MI . Interferon-induced 2’-5’adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med 1983; 157: 2140–2146.
Hylton W, Cayley J, Dore C, Denman AM . 2’,5’-Oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis 1986; 45: 220–224.
Tsao BP, Cantor RM, Grossman JM et al. PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest 1999; 103: 1135–1140.
Raziuddin S, Al-Janadi MA, Alwabel AA . T-cell receptor α/β chain-CD3 protein complex defect in systemic lupus erythematosus: T-cell function. Am J Med 1992; 93: 461–466.
Ytterberg SR, Schnitzer TJ . Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 1982; 25: 401–406.
Hauptmann R, Swetly P . A novel class of human type I interferons. Nucleic Acids Res 1985; 13: 4739–4749.
Adolf GR . Monoclonal antibodies and enzyme immunoassays specific for human interferon (IFN) ω 1: evidence that IFN- ω 1 is a component of human leukocyte IFN. Virology 1990; 175: 410–417.
Cederblad B, Blomberg S, Vallin H et al. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J Autoimmunol 1998; 11: 465–470.
Blomberg S, Eloranta ML, Cederblad B et al. Presence of cutaneous interferon-α producing cells in patients with systemic lupus erythematosus. Lupus 2001; 10: 484–490.
Ronnblom LE, Alm GV, Oberg KE . Possible induction of systemic lupus erythematosus by interferon-α treatment in patient with a malignant carcinoid tumour. J Intern Med 1990; 227: 207–210.
Ronnblom LE, Alm GV, Oberg KE . Autoimmunity after alpha-interferon therapy for malignant carcinoid tumour. Ann Intern Med 1991; 115: 178–183.
Neubauer RH, Goldstein L, Rabin H, Stebbing N . Stimulation of in vitro immunoglobulin production by interferon-α. J Immunol 1985; 134: 299–303.
Marrack P, Kappler J, Mitchell T . Type I interferon keep activated T cells alive. J Exp Med 1999; 189: 521–529.
Su L, David M . Inhibition of B cell receptor-mediated apoptosis by IFN. J Immunol 1999; 162: 6317–6321.
Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J . Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 2001; 294: 1540–1543.
Ronnblom L, Alm GV . An etiopathogenic role for the type I IFN system in SLE. Trends Immunol 2001; 22: 427–431.
Shan XC, Bourdeau A, Rhoton A et al. Characterization and mapping to human chromosome 8q24.3 of Ly-6-related gene 9804 encoding an apparent homologue of mouse TSA-1. J Immunol 1998; 160: 197–208.
Godfrey DI, Masciantonio M, Tucek CL et al. Thymic shared antigen-1, a novel thymocyte marker discriminating immature from mature thymocyte subsets. J Immunol 1992; 148: 2006–2011.
Liossis SC, Ding XZ, Dennis GJ, Tsokos GC . Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. J Clin Invest 1998; 101: 1448–1457.
Brundula V, Rivas LJ, Blasini AM et al. Diminished levels of T cell receptor ζ chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1908–1916.
Noda S, Kosugi A, Saitoh SI, Narumiya S, Hamaoka T . Protection from anti-TCR/CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1/stem cell antigen-2. J Exp Med 1996; 183: 2355–2360.
Saitoh SI, Kosugi A, Noda S et al. Modulation of TCR-mediated signaling pathway by thymic shared antigen-1(TSA-1)/stem cell antigen-2(Sca-2). J Immunol 1995; 155: 5574–5581.
Dumont FJ, Coker LZ . Interferon-α/β enhances the expression of Ly-6 antigens on T cells in vivo and in vitro. Eur J Immunol 1986; 16: 735–740.
Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531–537.
Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatosus 1982; 25: 1271–1277.
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH . Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630–640.
Lockhart DJ, Winzeler EA . Genomics, gene expression and DNA arrays. Nature 2000; 405: 827–836.
Acknowledgements
This work was supported by the National Nature Science Foundation of China (No. 39730430). We thank the patients for providing the blood samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Han, GM., Chen, SL., Shen, N. et al. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 4, 177–186 (2003). https://doi.org/10.1038/sj.gene.6363966
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363966
Keywords
This article is cited by
-
Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response
Modern Pathology (2022)
-
Clinical features and expression of type I interferon-inducible genes in systemic lupus erythematosus patients harboring rs1143679 polymorphism in China: a single-center, retrospective study
Clinical Rheumatology (2021)
-
Immunological pathogenesis and treatment of systemic lupus erythematosus
World Journal of Pediatrics (2020)
-
Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice
Arthritis Research & Therapy (2019)
-
Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus
Communications Biology (2019)